Multimodal treatment for mesothelioma shows survival benefit

A multimodal treatment regimen of surgery, chemotherapy and radiotherapy produced an impressive one-year survival rate of 79.6 percent for patients with malignant pleural mesothelioma, according to a recent study.
Asbestos